Monday, December 30, 2019

AstraZeneca, Merck score win with Lynparza approval for pancreatic cancer

AstraZeneca, Merck score win with Lynparza approval for pancreatic cancer The drug is now the only approved medicine in biomarker-selected patients with advanced pancreatic cancer.

from Moneycontrol Business News https://ift.tt/35awRrv

No comments:

Post a Comment

Oil prices may face further pressure amid OPEC+ supply glut: Seth R Freeman

Seth R Freeman of GlassRatner Advisory notes India's role in stabilizing oil prices by purchasing discounted Russian oil amidst tariff a...